HarmoucheEStuevePHowlandMA, et al.Massive apixaban overdose confirmed with blood concentrations and managed without bleeding: A single case report. J Pharm Pract. 2023;12:8971900231177570. doi: 10.1177/08971900231177570.
2.
ZhengWDaiXXuB, et al.Discovery and development of factor Xa inhibitors (2015-2022). Front Pharmacol. 2023. Online ahead of print. doi:10.3389/fphar.2023.1105880.
3.
ScuttGAllenMWaxmanD. Estimating a drug’s elimination rate-constant or half-life from a single blood sample: A practical approach with particular benefits for critically ill/vulnerable patients. Biosystems. 2019. Online ahead of print. doi:10.1016/j.biosystems.2019.103996.
4.
FrostCNepalSWangJ, et al.Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects. Br J Clin Pharmacol. 2013;76:776-786.
5.
FranckBDulaurentSEl BalkhiS, et al.Self-poisoning with 60 tablets of apixaban, a pharmacokinetics case report. Br J Clin Pharmacol. 2019;85:270-272.
